Age of Onset of Polycystic Ovarian Syndrome in Girls May Be Earlier Than Previously Thought

Journal of Pediatric and Adolescent Gynecology

Volumn 24, Issue 1, 2011, Pages 15-20

  Bronstein, Jason ^a   Tawdekar, Sonali ^a   Liu, Yinghua ^a   Pawelczak, Melissa ^a   David, Raphael ^a   Shah, Bina ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescents; Hyperandrogenism; Polycystic ovary syndrome

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BIRTH WEIGHT; BODY HEIGHT; BODY MASS; BREAST DEVELOPMENT; CONTROLLED STUDY; ETHNICITY; FAMILY HISTORY; FEMALE; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MENARCHE; OBESITY; ONSET AGE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PUBERTY; RISK FACTOR; SYSTEMATIC REVIEW;

ADOLESCENT; AGE OF ONSET; CHILD; FEMALE; HUMANS; POLYCYSTIC OVARY SYNDROME; RISK FACTORS;

EID: 78751697857     PISSN: 10833188     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpag.2010.06.003     Document Type: Article

References (52)

1. Michelmore K.F., Balen A.H., Dunger D.B., et al. Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol (Oxf) 1999, 51:779.
2. Driscoll D.A. Polycystic ovary syndrome in adolescence. Semin Reprod Med 2003, 21:301.
3. Rosenfield R.L. Clinical review: Identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab 2007, 92:787.
4. Barnes R.B., Rosenfield R.L., Ehrmann D.A., et al. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab 1994, 79:1328.
5. Ghizzoni L., Virdis R., Vottero A., et al. Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 1996, 81:601.
6. Ceelen M., van Weissenbruch M.M., Vermeiden J.P., et al. Pubertal development in children and adolescents born after IVF and spontaneous conception. Hum Reprod 2008, 23:2791.
7. Sir-Petermann T., Maliqueo M., Angel B., et al. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum Reprod 2002, 17:2573.
8. Legro R.S., Driscoll D., Strauss J.F., et al. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA 1998, 95:14956.
9. Battaglia C., Regnani G., Mancini F., et al. Polycystic ovaries in childhood: a common finding in daughters of PCOS patients. A pilot study. Hum Reprod 2002, 17:771.
10. Vink J.M., Sadrzadeh S., Lambalk C.B., et al. Heritability of polycystic ovary syndrome in Dutch twin-family study. J Clin Endocrinol Metab 2006, 91:2100.
11. Sir-Petermann T., Codner E., Pérez V., et al. Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2009, 94:1923.
12. Silfen M.E., Denburg M.R., Manibo A.M., et al. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. J Clin Endocrinol Metab 2003, 88:4682.
13. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81:19. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.
14. Rachmiel M., Kives S., Atenafu E., et al. Primary amenorrhea as a manifestation of polycystic ovarian syndrome in adolescents: a unique subgroup? Arch Pediatr Adolesc Med 2008, 162:521.
15. Bhattacharya S.M. Metabolic syndrome in females with polycystic ovary syndrome and International Diabetes Federation criteria. J Obstetr Gynaecol Res 2008, 34:62.
16. Andiran N., Yordam N. Lipoprotein(a) levels in girls with premature adrenarche. J Paediatr Child Health 2008, 44:138.
17. Ibañez L., López-Bermejo A., Callejo J., et al. Polycystic ovaries in nonobese adolescents and young women with ovarian androgen excess: relation to prenatal growth. J Clin Endocrinol Metab 2008, 93:196.
18. Valdés P., Cerda A., Barrenechea C., et al. No association between common Gly972Arg variant of the insulin receptor substrate-1 and polycystic ovary syndrome in Southern Chilean women. Clin Chim Acta 2008, 390:63.
19. Rossi B., Sukalich S., Droz J., et al. Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome. J Clin Endocrinol Metab 2008, 93:4780.
20. Demirel F., Bideci A., Cinaz P., et al. Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome. Clin Endocrinol 2007, 67:129.
21. Sun L., Fu Q. Three-dimensional transrectal ultrasonography in adolescent patients with polycystic ovarian syndrome. Int J Gynaecol Obstet 2007, 98:34.
22. Luque-Ramírez M., Alvarez-Blasco F., Mendieta-Azcona C., et al. Obesity is the major determinant of the abnormalities in blood pressure found in young women with the polycystic ovary syndrome. J Clin Endocrinol Metab 2007, 92:2141.
23. Nazari T., Bayat R., Hamedi M. Metformin therapy in girls with polycystic ovary syndrome: a self-controlled clinical trial. Arch Iran Med 2007, 10:176.
24. Littlejohn E.E., Weiss R.E., Deplewski D., et al. Intractable early childhood obesity as the initial sign of insulin resistant hyperinsulinism and precursor of polycystic ovary syndrome. J Pediatr Endocrinol Metab 2007, 20:41.
25. Sharquie K.E., Al-Bayatti A.A., Al-Ajeel A.I., et al. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome. Saudi Med J 2007, 28:1039.
26. Chen M.J., Yang W.S., Yang J.H., et al. Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome. Hypertension 2007, 49:1442.
27. Triantafyllopoulou M., Whitington P.F., Melin-Aldana H., et al. Hepatic adenoma in an adolescent with elevated androgen levels. J Pediatr Gastroenterol Nutr 2007, 44:640.
28. Ben Salem Hachmi L., Ben Salem Hachmi S., Bouzid C., et al. [Hypertension in polycystic ovary syndrome]. Arch Mal Coeur Vaiss 2006, 99:687.
29. Hoppin A.G., Katz E.S., Kaplan L.M., et al. Case records of the Massachusetts General Hospital. Case 31-2006. A 15-year-old girl with severe obesity. N Engl J Med 2006, 355:1593.
30. Mortensen M., Rosenfield R.L., Littlejohn E. Functional significance of polycystic-size ovaries in healthy adolescents. J Clin Endocrinol Metab 2006, 91:3786.
31. Harris Y.S., McDonald S.B. An African American female with irregular menses and weight gain. Pediatr Nurs 2006, 32:354.
32. De Leo V., Musacchio M.C., Morgante G., et al. Metformin treatment is effective in obese teenage girls with PCOS. Hum Reprod 2006, 21:2252.
33. Glueck C.J., Aregawi D., Winiarska M., et al. Metformin-diet ameliorates coronary heart disease risk factors and facilitates resumption of regular menses in adolescents with polycystic ovary syndrome. J Pediatr Endocrinol 2006, 19:831.
34. Fulghesu A.M., Angioni S., Portoghese E., et al. Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome. Fertil Steril 2006, 86:398.
35. Nicoletti A. Paradigm shift. J Pediatr Adolesc Gynecol 2006, 19:317.
36. Vambergue A., Lautier C., Valat A.S., et al. Follow-up study of two sisters with type A syndrome of severe insulin resistance gives a new insight into PCOS pathogenesis in relation to puberty and pregnancy outcome: a case report. Hum Reprod 2006, 21:1274.
37. Leibel N.I., Baumann E.E., Kocherginsky M., et al. Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome. J Clin Endocrinol Metab 2006, 91:1275.
38. Mastorakos G., Koliopoulos C., Deligeoroglou E., et al. Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome. Fertil Steril 2006, 85:420.
39. Yoo R.Y., Dewan A., Basu R., et al. Increased luteinizing hormone pulse frequency in obese oligomenorrheic girls with no evidence of hyperandrogenism. Fertil Steril 2006, 85:1049.
40. Bridger T., MacDonald S., Baltzer F., et al. Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome. Arch Pediatr Adolesc Med 2006, 160:241.
41. Coviello A.D., Legro R.S., Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab 2006, 91:492.
42. Broder-Fingert S., Shah B., Kessler M., et al. Evaluation of adolescents for polycystic ovary syndrome in an urban population. J Clin Res Pediatr Endocrinol 2009, 1:188.
43. Ibañez L., Potau N., Virdis R., et al. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1993, 76:1599.
44. Ibañez L., Potau N., Zampolli M., et al. Hyperinsulinemia and decreased insulin-like growth factor-binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. J Clin Endocrinol Metab 1997, 82:2283.
45. Ibañez L., Potau N., Chacon P., et al. Hyperinsulinaemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche. Diabetologia 1998, 41:1057.
46. Ibanez L., Ong K., de Zegher F., et al. Fat distribution in non-obese girls with and without precocious pubarche: central adiposity related to insulinaemia and androgenaemia from prepuberty to postmenarche. Clin Endocrinol (Oxf) 2003, 58:372.
47. Meas T., Chevenne D., Thibaud E., et al. Endocrine consequences of premature pubarche in post-pubertal Caucasian girls. Clin Endocrinol (Oxf) 2002, 57:101.
48. Reinehr T., de Sousa G., Roth C.L., et al. Androgens before and after weight loss in obese children. J Clin Endocrinol Metab 2005, 90:5588.
49. McCartney C.R., Prendergast K.A., Chhabra S., et al. The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism. J Clin Endocrinol Metab 2006, 91:1714.
50. Wozniak M., Murias M. [Xenoestrogens: endocrine disrupting compounds]. Ginekol Pol 2008, 79:785.
51. Huang W.J., Liu J.Y., Li L.N. [Analysis of environmental factors and polycystic ovary syndrome]. Zhonghua Fu Chan Ke Za Zhi 2007, 42:302.
52. Khan U. Polycystic ovary syndrome in adolescents. J Pediatr Adolesc Gynecol 2007, 20:101.